Status:
COMPLETED
Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)
Lead Sponsor:
Organon and Co
Conditions:
Asthma
Eligibility:
All Genders
15+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate improved results of treatment for patients entering an emergency department with asthma attacks when given an investigational IV administration of an approved ...
Eligibility Criteria
Inclusion
- Individuals with acute asthma
Exclusion
- Women of child bearing age
- History of Chronic Obstructive Pulmonary Disease (COPD)
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
650 Patients enrolled
Trial Details
Trial ID
NCT00092989
Start Date
July 1 2004
End Date
March 1 2007
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.